Stock·NYSE·Technology
Leidos Holdings Inc (LDOS)
- Market cap
- $15.70B
- P/E
- 11.66
- Dividend yield
- 1.38%
- Street target
- $145.00median of 17 analysts
- 52-week range
- $98.86 $205.77
The short version
Where LDOS stands today, in four lines, and what CleaRank Financial AI makes of it.
LDOS at a glance
Leidos Holdings Inc (LDOS): Hold, 51/100 on CleaRank's AI score.
- Trend Down: the price is below both its 50- and 200-day moving averages ($130.52 and $144.03).
- Earnings LDOS beat estimates in 7 of its last 7 quarters, yet fell the next day after 6 of those beats.
- Insiders Insiders sold $10.2M and made no open-market purchases over the last 18 months.
- Valuation P/E of 11.7 against 35.1 for the Technology sector: a discount to peers (-67%).
Figures as of October 17, 2026.
CleaRank Financial AI
CleaRank rates Leidos Holdings Inc (LDOS) Hold, with a model score of 51/100.
Valuation lifts the score most: the P/E of 11.66 is 66.8% below the sector median (a discount to peers) and the P/S of 0.89 is 88.3% below the sector median. The trend holds it back most: the price is 13.30% below its 200-day average and 4.33% below its 50-day average, and the 50-day average is 9.38% below the 200-day. The 50-day average stands at $130.52 and the 200-day at $144.03. Over the past year the price fell 32.29%.
Only on CleaRank
Figures we compute ourselves from LDOS's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
0/4Price above its 50-day average ›
The price of $124.87 is 4.3% below the 50-day simple moving average of $130.52.Price above its 200-day average ›
The price is 13.3% below the 200-day simple moving average of $144.03.50-day average above the 200-day ›
The 50-day average ($130.52) is 9.4% below the 200-day average ($144.03), the arrangement of a falling longer-term trend.In the upper half of its 52-week range ›
The price sits at 24% of its 52-week range, between $98.86 and $205.77.
LDOS share price
Pick a period: each tab shows how far LDOS has moved over it, to the last close.
Today's trading
Where LDOS sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
5/5P/E below the sector median ›
The trailing P/E of 11.66 is 66.8% below the Technology median of 35.1.P/S below the sector median ›
The price-to-sales ratio of 0.89 is 88.3% below the sector median of 7.6.Profitable over the last 12 months ›
Net income over the last 12 months was $1.4B on revenue of $17.6B, a net margin of 7.8%.Beat estimates in most recent reports ›
LDOS beat the EPS estimate in 7 of its last 7 reports.Pays a dividend ›
The trailing dividend yield is 1.38%, or $1.72 a share a year.
Key statistics
The headline figures for LDOS.
As of October 17, 2026, LDOS trades at $124.87, with a market value of $15.70B, a P/E ratio of 11.66 and a dividend yield of 1.38%.
What the numbers say
CleaRank Financial AI's reading of LDOS's valuation, growth and risks.
LDOS is priced at a trailing P/E of 11.66, against a Technology median of 35.1. That places the P/E 66.8% below the sector median, a level the peer comparison on this page labels a discount to peers. On sales, the stock trades at 0.89 times, 88.3% below the sector median of 7.6. Its market capitalisation is $15.7B, and trailing earnings stand at $10.71 a share.
Revenue grew 7.20%, which leaves LDOS 17.0 percentage points slower than the sector median of 24.2%. On profitability, the company turns sales into earnings at a net margin of 7.80% and an operating margin of 11.72%. Its return on equity of 27.78% sits above the sector median of 13.4%. Debt-to-equity stands at 1.23, and the trailing dividend yield is 1.38%, equal to $1.72 a share a year.
Leidos reported $3.26 a share in the August 4, 2026 report, ahead of the $2.91 estimate and a beat of 12.03%. Despite the beat, the stock dropped 2.87% in the session that followed.
The record is a clean sweep: 7 beats in 7 reports, but beats have not guaranteed gains: the stock fell the next day after 6 of them. Analysts' average EPS estimate for this fiscal year is $12.41, which would be growth of 3.5%, and $12.74 for next year (growth of 2.7%).
Normal swings for LDOS run at about 2.04% a day. Until the price regains its moving averages, the trend works against holders. The price is 39.32% below its 52-week high of $205.77. Insiders sold $10.2M over the last 18 months and bought none on the open market, though sales of this kind are often planned in advance and say less than purchases would.
LDOS against the Technology sector
How LDOS compares with the median Technology stock CleaRank tracks.
Price to earnings vs sector: LDOS trades at a notable discount to sector peers (-67%), which may indicate undervaluation or specific company headwinds.
Return vs XLK: Since May 6, 2025, LDOS has lost 19.3% against a gain of 73.7% for XLK.
Performance against XLK
LDOS and the Technology sector fund over the same days.
Revenue and earnings
How much LDOS sells, and how much of it becomes profit.
Revenue growth: Revenue grew 3.1% in FY2025 to $17.2B, from $16.7B a year earlier.
Profit margin: The net margin was 8.5% in FY2025, up from 7.5% the year before.
Profitable: LDOS earned $1.5B in FY2025.
Earnings reality check
Did LDOS beat what analysts expected, and how did the stock react?
Earnings record: LDOS beat the analyst estimate in 7 of the last 7 quarters.
Market reaction: The stock fell in the first session after 6 of those 7 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Aug 4, 2026after close | $2.91 | $3.26 | +12.03% | -2.87% | +7.88% |
| May 5, 2026after close | $2.91 | $3.13 | +7.56% | -1.67% | -6.41% |
| Nov 4, 2025after close | $2.72 | $3.05 | +12.13% | -2.25% | -0.65% |
| Aug 5, 2025after close | $2.66 | $3.21 | +20.68% | +0.90% | +2.94% |
| May 6, 2025after close | $2.50 | $2.97 | +18.80% | -0.02% | +0.44% |
| Feb 11, 2025after close | $2.27 | $2.37 | +4.41% | -0.55% | -4.43% |
| Oct 29, 2024after close | $2.02 | $2.93 | +45.05% | -0.06% | +2.27% |
As of October 17, 2026, LDOS has beaten the analyst EPS estimate in 7 of its last 7 reported quarters and fell in the first trading session after 6 of those beats; its latest report, on August 4, 2026, came in 12.03% above the estimate and the stock moved -2.87% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
2/3RSI not overbought or oversold ›
The 14-day RSI is 52.3, in neutral territory.RSI above 50 ›
An RSI of 52.3 is above the 50 midpoint, so buyers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank AI analysis of LDOS
The score, the reasoning behind it, and what could move the price next.
Leidos Holdings Inc (LDOS) is in a downtrend: the price of $124.87 sits 13.30% below its 200-day average of $144.03 and 4.33% below its 50-day average of $130.52. Within its 52-week range the stock is near the bottom, 26.31% above the low of $98.86 and 39.32% below the high of $205.77.
Short-term and long-term price action disagree. Over the past month the price fell 3.46%, yet over the past three months it rose 17.27%, and over the past year it fell 32.29%. Momentum sits in the neutral zone with a 14-day RSI of 52.3, while the MACD line is negative.
Earnings beat ›
The August 4, 2026 report beat the EPS estimate by 12.03%, and the share price fell 2.87% in the first session after it.
Source: Earnings report, August 4, 2026
Analyst downgrade ›
JP Morgan downgraded it to Neutral from Overweight on October 8, 2026.
Source: Analyst action, JP Morgan, October 8, 2026
- Two levels matter most right now: the 50-day SMA at $130.52 above the price, and the 20-day EMA at $122.70 below it.
- A 14-day RSI of 52.3 is neutral, and the MACD line is negative. Readings above 70 or below 30 would signal stretched momentum in either direction.
- LDOS beat estimates in 7 of the last 7 reports, yet the share price fell 2.87% in the first session after the August 4, 2026 report.
LDOS sits beneath both its 50-day ($130.52) and 200-day ($144.03) averages, and that placement is why the trend reads down. A recovery back above the 50-day would be the first sign of repair. The nearest level above the price is the 50-day SMA at $130.52.
The next level below the price is the 20-day EMA, at $122.70.
Technical indicators
Momentum and trend for LDOS, from its daily closes.
As of October 17, 2026, with LDOS at $124.87, its 14-day RSI is 52.3 (neutral territory), its 50-day simple moving average is $130.52 and its 200-day is $144.03.
Calculated by CleaRank on daily closes as of October 17, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What LDOS moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 17, 2026, LDOS's 1-year correlation of daily returns is +0.23 with S&P 500 (SPY), +0.15 with Nasdaq 100 (QQQ), +0.07 with Bitcoin (BTC) and +0.05 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
1/3Most analysts rate it a buy ›
6 of 17 analysts rate it a buy or strong buy, 11 a hold and 0 a sell.Median target above the price ›
The median 12-month target of $145.00 is 16.1% above the price.More buy ratings than three months ago ›
6 of 17 rate it a buy now, against 7 of 17 three months ago.
LDOS Wall Street View
12-month price targets
The price, $124.87, sits below every analyst's target.
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 8, 2026 | JP Morgan | Downgrade | Neutral |
| Oct 7, 2026 | Citigroup | Maintains | Buy |
| Oct 6, 2026 | Jefferies | Maintains | Hold |
| Oct 6, 2026 | TD Cowen | Maintains | Hold |
| Sep 18, 2026 | B of A Securities | Maintains | Neutral |
| Aug 12, 2026 | Goldman Sachs | Maintains | Neutral |
As of October 17, 2026, 17 Wall Street analysts cover LDOS: 6 rate it a buy or strong buy, 11 a hold and 0 a sell or strong sell. Their 12-month price targets range from $127.00 to $225.00, with a median of $145.00, 16.1% above the price of $124.87.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
LDOS trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Entry Strategies pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from LDOS's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much LDOS tends to move, against the market and on its own.
The long record
LDOS's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
1/4Average daily move under 2% ›
The price has moved 2.04% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 48.6%, from November 2025 to June 2026; the price is still 36.7% below that peak.Most 1-year holds ended higher ›
78% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $35,045, against $42,058 in the S&P 500 (SPY).
LDOS Drawdowns & Recovery
As of October 17, 2026, LDOS's worst peak-to-trough fall over the last 10 years with dividends reinvested was -48.6% (November 2025 to June 2026); it is still 36.7% below that peak, and 78% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into LDOS in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: LDOS trailed the S&P 500 over this period: $35,045 against $42,058.
A $10,000 investment in LDOS in October 2016 would be worth about $35,045 today with dividends reinvested, compared with about $42,058 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to LDOS, and which have not.
Strongest month, November: an average of +7.30%, up in 7 of 10 years.
Weakest month, December: an average of -2.28%, up in 4 of 10 years.
This month, October: has averaged +0.69%, up in 5 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, LDOS's strongest calendar month has been November (average +7.30%, up in 7 of 10 years) and its weakest December (average -2.28%, up in 4 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in LDOS, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in LDOS today could grow to about $22,177 by 2036 in the base case, with a 90th-percentile outcome near $69,552 and a 10th-percentile outcome around $7,071. The simulation models price only; at today's 1.38% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
LDOS Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $172 for LDOS by 2030 in the base case, from $125 today (1.4x over 4 years). The 10th-percentile path ends near $83.34. These are outcomes of a Monte Carlo simulation run on LDOS's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $94.20 | $135 | $194 | |
| 2028 | $87.83 | $146 | $244 | |
| 2029 | $84.79 | $159 | $297 | |
| 2030 | $83.34 | $172 | $354 | |
| 2031 | $82.87 | $186 | $417 |
Method: a lognormal simulation of LDOS's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles.
Insider trading
What the people running the company have bought and sold.
LDOS insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Insider buying: No insider bought LDOS shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would.
As of October 17, 2026, LDOS insiders reported 13 open-market sales worth $10.2M and no open-market purchases over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Sep 30, 2026 | Harry M. Jansen Kraemer Jr.
Director
|
Grant | 463 | - |
| Sep 30, 2026 | Robert S Shapard
Director
|
Grant | 5 | - |
| Sep 1, 2026 | Gary Stephen May
Director
|
Sell | 1.0K | $140.8K |
| Aug 11, 2026 | Noel Brown Geer
Director
|
Sell | 10.0K | $1.4M |
| Jul 6, 2026 | Harry M. Jansen Kraemer Jr.
Director
|
Grant | 310 | - |
| Jun 30, 2026 | Daniel J. Antal
General Counsel
|
Grant | 5 | - |
| Jun 30, 2026 | Christopher R. Cage
Chief Financial Officer
|
Grant | 113 | - |
| Jun 30, 2026 | Harry M. Jansen Kraemer Jr.
Director
|
Grant | 565 | - |
| Jun 30, 2026 | Robert S Shapard
Director
|
Grant | 6 | - |
| Jun 30, 2026 | Roy E Stevens
Officer
|
Grant | 7 | - |
| May 8, 2026 | Gregory R. Dahlberg
Director
|
Grant | 1.1K | - |
| May 8, 2026 | David G Fubini
Director
|
Grant | 1.1K | - |
| May 8, 2026 | Noel Brown Geer
Director
|
Grant | 1.1K | - |
| May 8, 2026 | Tina W Jonas
Director
|
Grant | 1.1K | - |
| May 8, 2026 | Harry M. Jansen Kraemer Jr.
Director
|
Grant | 1.1K | - |
| May 8, 2026 | Gary Stephen May
Director
|
Grant | 1.1K | - |
| May 8, 2026 | Nancy A Norton
Director
|
Grant | 1.1K | - |
| May 8, 2026 | Patrick M Shanahan
Director
|
Grant | 1.1K | - |
| May 8, 2026 | Robert S Shapard
Director
|
Grant | 1.1K | - |
| May 7, 2026 | Gary Stephen May
Director
|
Sell | 1.5K | $197.0K |
| May 7, 2026 | Gary Stephen May
Director
|
Option | 3.3K | $250.9K |
| May 1, 2026 | Daniel J. Antal
General Counsel
|
Grant | 8 | - |
| May 1, 2026 | Harry M. Jansen Kraemer Jr.
Director
|
Grant | 9 | - |
| Apr 10, 2026 | Harry M. Jansen Kraemer Jr.
Director
|
Grant | 220 | - |
| Apr 7, 2026 | Elizabeth A Porter
Officer
|
Sell | 2.0K | $317.6K |
| Mar 31, 2026 | Daniel J. Antal
General Counsel
|
Grant | 2 | - |
| Mar 31, 2026 | Christopher R. Cage
Chief Financial Officer
|
Grant | 73 | - |
| Mar 31, 2026 | Harry M. Jansen Kraemer Jr.
Director
|
Grant | 363 | - |
| Mar 31, 2026 | Robert S Shapard
Director
|
Grant | 4 | - |
| Mar 31, 2026 | Roy E Stevens
Officer
|
Grant | 5 | - |
| Mar 16, 2026 | Gregory R. Dahlberg
Director
|
Option | 3.3K | $250.9K |
| Mar 6, 2026 | Daniel J. Antal
General Counsel
|
Grant | 4.2K | - |
| Mar 6, 2026 | Daniel A. Atkinson IV
Officer
|
Grant | 1.1K | - |
| Mar 6, 2026 | Thomas Arthur Bell
Chief Executive Officer
|
Grant | 37.3K | - |
| Mar 6, 2026 | Christopher R. Cage
Chief Financial Officer
|
Grant | 8.4K | - |
| Mar 6, 2026 | Leslie K. Fautsch
Officer
|
Grant | 4.1K | - |
| Mar 6, 2026 | Cindy Gruensfelder
Officer
|
Grant | 4.6K | - |
| Mar 6, 2026 | Stephen Edward Hull
Officer
|
Grant | 4.6K | - |
| Mar 6, 2026 | Jason M O'Connor
Officer
|
Grant | 3.9K | - |
| Mar 6, 2026 | Elizabeth A Porter
President
|
Grant | 4.6K | - |
| Mar 6, 2026 | Roy E Stevens
Officer
|
Grant | 4.6K | - |
| Mar 4, 2026 | Christopher R. Cage
Chief Financial Officer
|
Grant | 16 | - |
| Mar 4, 2026 | Noel Brown Geer
Director
|
Option | 6.2K | $587.1K |
| Feb 23, 2026 | Jason M O'Connor
Officer
|
Option | 1.3K | $78.2K |
| Feb 23, 2026 | Elizabeth A Porter
Officer
|
Option | 3.2K | $202.3K |
| Feb 20, 2026 | Christopher R. Cage
Chief Financial Officer
|
Option | 3.3K | $208.1K |
| Feb 20, 2026 | Harry M. Jansen Kraemer Jr.
Director
|
Option | 3.3K | $250.9K |
| Feb 19, 2026 | Robert S Shapard
Director
|
Option | 3.3K | $250.9K |
| Feb 12, 2026 | Daniel J. Antal
General Counsel
|
Grant | 3.2K | - |
| Feb 12, 2026 | Daniel A. Atkinson IV
Officer
|
Grant | 772 | - |
| Feb 12, 2026 | Thomas Arthur Bell
Chief Executive Officer
|
Grant | 65.4K | - |
| Feb 12, 2026 | Christopher R. Cage
Chief Financial Officer
|
Grant | 18.2K | - |
| Feb 12, 2026 | Leslie K. Fautsch
Officer
|
Grant | 4.4K | - |
| Feb 12, 2026 | Cindy Gruensfelder
Officer
|
Grant | 3.6K | - |
| Feb 12, 2026 | Stephen Edward Hull
Officer
|
Grant | 9.3K | - |
| Feb 12, 2026 | Jason M O'Connor
Officer
|
Grant | 1.8K | - |
| Feb 12, 2026 | Elizabeth A Porter
Officer
|
Grant | 13.7K | - |
| Feb 12, 2026 | Roy E Stevens
Officer
|
Grant | 13.2K | - |
| Jan 20, 2026 | Elizabeth A Porter
Officer
|
Sell | 3.0K | $576.6K |
| Jan 7, 2026 | Harry M. Jansen Kraemer Jr.
Director
|
Grant | 171 | - |
| Dec 31, 2025 | Daniel J. Antal
General Counsel
|
Grant | 0 | - |
| Dec 31, 2025 | Christopher R. Cage
Chief Financial Officer
|
Grant | 58 | - |
| Dec 31, 2025 | Harry M. Jansen Kraemer Jr.
Director
|
Grant | 305 | - |
| Dec 31, 2025 | Robert S Shapard
Director
|
Grant | 3 | - |
| Dec 31, 2025 | Roy E Stevens
Officer
|
Grant | 4 | - |
| Dec 19, 2025 | Elizabeth A Porter
Officer
|
Sell | 3.0K | $543.1K |
| Dec 2, 2025 | Mary Vicki Schmanske
Officer
|
Grant | 5.3K | - |
| Nov 19, 2025 | James F. Carlini
Chief Technology Officer
|
Grant | 1.1K | - |
| Oct 7, 2025 | Harry M. Jansen Kraemer Jr.
Director
|
Grant | 164 | - |
| Sep 30, 2025 | Daniel J. Antal
General Counsel
|
Grant | 0 | - |
| Sep 30, 2025 | Christopher R. Cage
Chief Financial Officer
|
Grant | 53 | - |
| Sep 30, 2025 | Harry M. Jansen Kraemer Jr.
Director
|
Grant | 279 | - |
| Sep 30, 2025 | Robert S Shapard
Director
|
Grant | 3 | - |
| Sep 30, 2025 | Roy E Stevens
Officer
|
Grant | 3 | - |
| Sep 4, 2025 | Stephen Edward Hull
Officer
|
Sell | 12.5K | $2.2M |
| Sep 4, 2025 | Stephen Edward Hull
Officer
|
Option | 14.4K | $1.5M |
| Aug 27, 2025 | Noel Brown Geer
Director
|
Option | 3.3K | $250.9K |
| Aug 25, 2025 | Roy E Stevens
Officer
|
Sell | 2.7K | $493.4K |
| Aug 25, 2025 | Roy E Stevens
Officer
|
Option | 7.5K | $470.5K |
| Aug 20, 2025 | Stephen Edward Hull
Officer
|
Sell | 12.9K | $2.3M |
| Aug 15, 2025 | Stephen Edward Hull
Officer
|
Option | 12.8K | $1.1M |
| Aug 11, 2025 | Gary Stephen May
Director
|
Sell | 2.0K | $356.1K |
| Aug 11, 2025 | Gregory R. Dahlberg
Director
|
Sell | 952 | $168.9K |
| Aug 11, 2025 | Gregory R. Dahlberg
Director
|
Option | 2.9K | $352.3K |
| Aug 8, 2025 | Stephen Edward Hull
Officer
|
Sell | 7.5K | $1.3M |
| Jul 8, 2025 | Harry M. Jansen Kraemer Jr.
Director
|
Grant | 200 | - |
| Jun 30, 2025 | Daniel J. Antal
General Counsel
|
Grant | 1 | - |
| Jun 30, 2025 | Christopher R. Cage
Chief Financial Officer
|
Grant | 64 | - |
| Jun 30, 2025 | Robert S Shapard
Director
|
Grant | 4 | - |
| May 9, 2025 | Gregory R. Dahlberg
Director
|
Sell | 1.3K | $193.2K |
| May 9, 2025 | Gregory R. Dahlberg
Director
|
Grant | 873 | - |
| May 9, 2025 | David G Fubini
Director
|
Grant | 873 | - |
| May 9, 2025 | Noel Brown Geer
Director
|
Grant | 873 | - |
| May 9, 2025 | Tina W Jonas
Director
|
Grant | 1.4K | - |
| May 9, 2025 | Harry M. Jansen Kraemer Jr.
Director
|
Grant | 873 | - |
| May 9, 2025 | Gary Stephen May
Director
|
Grant | 873 | - |
| May 9, 2025 | Nancy A Norton
Director
|
Grant | 873 | - |
| May 9, 2025 | Patrick M Shanahan
Director
|
Grant | 873 | - |
| May 9, 2025 | Robert S Shapard
Director
|
Grant | 873 | - |
| May 2, 2025 | Daniel J. Antal
General Counsel
|
Grant | 4 | - |
Source: TwelveData, from SEC Form 4 filings
Questions people ask
Answered from the figures on this page, as of October 17, 2026.